At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
In Brief
An observational study for Lung Neoplasms. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This is a prospective diagnostic pilot study to create hypotheses regarding immunocytochemistry (ICC) PD-L1 analysis of pleural effusions in NSCLC patients as compared to the reference standard of PD-L1 immunohistochemistry (IHC). This comparison will be done to assess sensitivity and specificity of PD-L1 detection by ICC in pleural effusions.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Neoplasms
CountriesGermany
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2016
Enrollment StartOct 2016
Primary CompletionDec 2018
TodayJul 2026
First PostedAug 4, 2016
Enrollment StartOct 1, 2016
Primary CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 9.9 years ago